Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FENNEC PHARMACEUTICALS INC.

(FENC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société FENNEC PHARMACEUTICALS INC.
01/17FENNEC PHARMACEUTICALS : Corporate Presentation January 2022
PU
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fenne..
PR
2021FENNEC PHARMACEUTICALS : Receives Complete Response Letter from the FDA for its New Drug A..
PU
2021Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug ..
AQ
2021Fennec pharmaceuticals expects to receive complete response letter from the fda for its..
AQ
2021FENNEC PHARMACEUTICALS : Expects to Receive Complete Response Letter from the FDA for its ..
PU
2021FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its..
GL
2021FENNEC PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Conditio..
AQ
2021Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Busi..
GL
2021Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Busi..
GL
2021FENNEC PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
AQ
2021FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
2021Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Bus..
GL
2021FENNEC PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
2021Fennec Announces Results of Annual Meeting
GL
2021FENNEC PHARMACEUTICALS : ANNOUNCES AMENDMENT TO INCREASE EXISTING SENIOR DEBT FACILITY (Fo..
PU
2021FENNEC PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Other Events, Fi..
AQ
2021Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
GL
2021FENNEC PHARMACEUTICALS : Announces FDA Acceptance of New Drug Application Resubmission for..
AQ
2021FENNEC PHARMACEUTICALS : ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION RESUBMISSION FOR..
PU
2021FENNEC PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021FENNEC PHARMACEUTICALS : Announces fda acceptance of new drug application resubmission for..
PU
2021Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission fo..
GL
2021FENNEC PHARMACEUTICALS : Resubmits new drug application to u.s. food and drug administrati..
AQ
2021FENNEC PHARMACEUTICALS : Resubmits New Drug Application to U.S. Food and Drug Administrati..
AQ
2021Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Busi..
GL
2021FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
2020Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Busi..
GL
2020Fennec Announces Issuance of U.S. Patent for PEDMARK™
GL
2020Law Offices of Howard G. Smith Continues Investigation of Fennec Pharmaceuticals Inc. (..
BU
2020THE LAW OFFICES OF FRANK R. CRUZ : Continues Its Investigation of Fennec Pharmaceuticals I..
BU
2020GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Continues Investigation..
BU
2020Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Fennec Pharma..
BU
2020FENNEC ALERT : Bragar Eagel & Squire, P.C. is Investigating Fennec Pharmaceuticals, Inc. o..
BU
2020INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claims Against ..
BU
2020GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
2020THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Fennec Pharmaceuticals Inc. ..
BU
2020Law Offices of Howard G. Smith Announces Investigation of Fennec Pharmaceuticals Inc. (..
BU
2020INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Fen..
BU
2020Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
GL
2020Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Bus..
GL
2020Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
GL
2020Fennec Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Busi..
GL
2020Fennec Announces Exercise and Closing of Underwriters' Option to Purchase Additional Sh..
GL
2020Fennec Announces Closing of Public Offering
GL
2020Fennec Announces Proposed Public Offering of Common Shares
GL
2020Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug ..
GL
2020Fennec Announces Issuance of U.S. Patent for Use of PEDMARK™
GL
2020Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Auth..
GL
2020Fennec Provides Business Update and Announces Fiscal Year 2019 Financial Results
GL
2020Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U...
GL
2019Fennec Provides Business Update and Announces Third Quarter 2019 Financial Results
GL
2019Fennec to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019
GL
2019Fennec Appoints Shubh Goel as Chief Commercial Officer
GL
2019Fennec Provides Business Update and Announces Second Quarter 2019 Financial Results
GL
2019Fennec Announces Results of Annual Meeting
GL
2019Fennec Provides Business Update and Announces First Quarter 2019 Financial Results
GL
2019Fennec Provides Business Update and Announces Fiscal Year 2018 Financial Results
GL
2019Fennec Pharmaceuticals Announces $12.5 Million Debt Financing With Bridge Bank
GL
2018Fennec Pharmaceuticals Initiates Rolling New Drug Application to U.s. Food and Drug Adm..
GL
2018FENNEC PHARMACEUTICALS : Announces Scientific Symposium on Ototoxicity in Pediatric Cancer..
PU
2018Fennec Pharmaceuticals Announces Scientific Symposium on Ototoxicity in Pediatric Cance..
GL
2018Fennec Provides Business Update and Announces Third Quarter 2018 Financial Results
GL
2018Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results
GL
2018Fennec Pharmaceuticals Receives Positive Opinion on the Pediatric Investigation Plan Fr..
GL
2018Fennec Announces Publication of Pedmark(TM) Siopel 6 Clinical Data in the New England J..
GL
2018Fennec Pharmaceuticals Set to Join Russell 3000 Index
GL
2018Fennec Announces Results of Annual Meeting
GL
2018Fennec Provides Business Update and Announces First Quarter 2018 Financial Results
GL
2018Fennec Pharmaceuticals Receives Breakthrough Therapy Designation by FDA for PEDMARK&tra..
GL
2018Fennec Provides Business Update and Announces Fiscal Year Ended December 31, 2017 Finan..
GL
2017Fennec Announces Closing of Public Offering
GL
2017Fennec Announces Pricing of Public Offering
GL
2017Fennec Announces Proposed Public Offering of Common Shares
GL
1  2Next
Upcoming event on FENNEC PHARMACEUTICALS INC.
03/30/22